Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0533

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease ; day:6 ; month:9 ; year:2018 ; pages:1-11
Acta neuropathologica ; (6.9.2018), 1-11

Creator: Pickett, Eleanor K.

Contributor: Rose, Jamie
McCrory, Caoimhe
McKenzie, Chris-Anne
King, Declan
Smith, Colin
Gillingwater, Thomas H.
Henstridge, Christopher M.
Spires-Jones, Tara L.
SpringerLink (Online service)

DOI: 10.1007/s00401-018-1903-2

URN: urn:nbn:de:101:1-2018102419392464714684

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pickett, Eleanor K.
Rose, Jamie
McCrory, Caoimhe
McKenzie, Chris-Anne
King, Declan
Smith, Colin
Gillingwater, Thomas H.
Henstridge, Christopher M.
Spires-Jones, Tara L.
SpringerLink (Online service)

Other Objects (12)

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

Alzheimer's disease: synaptic dysfunction and Aβ

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia

Related objects

Reset password